Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator

2004 ◽  
Vol 27 (7) ◽  
pp. 971-975 ◽  
Author(s):  
ROSE M.F.L. SILVA ◽  
LLUIS MONT ◽  
SANTIAGO NAVA ◽  
ULISES ROJEL ◽  
MARIONA MATAS ◽  
...  
2018 ◽  
Vol 28 (6) ◽  
pp. 890-893
Author(s):  
Hisaaki Komaki ◽  
Takashi Nakashima ◽  
Shinya Minatoguchi

AbstractIn some patients with Kawasaki disease, a prior myocardial infarction causes ventricular tachycardia in the chronic post-myocardial infarction phase. We report the case of a 41-year-old man with symptomatic and haemodynamically unstable ventricular tachycardia in whom substrate ablation was performed for the ventricular tachycardia before insertion of an implantable cardioverter-defibrillator.


Author(s):  
Zofia Lasocka ◽  
Alicja Dąbrowska-Kugacka ◽  
Ewa Lewicka ◽  
Aleksandra Liżewska-Springer ◽  
Tomasz Królak

In patients with idiopathic ventricular fibrillation (VF), recurrent implantable cardioverter-defibrillator (ICD) shocks might increase mortality risk and reduce patients’ quality of life. Catheter ablation of triggering ectopic beats is considered to be an effective method. We present a patient with recurrent VF, caused by the “R on T” premature ventricular complexes. In the presented case radiofrequency catheter ablation efficiently eliminated arrhythmia trigger, which was possible to detect thanks to the intracardiac electrocardiograms (ECG’s) stored in the ICD.


2020 ◽  
Vol 9 (5) ◽  
pp. 375-385
Author(s):  
Michael E Field ◽  
Laura Goldstein ◽  
Stephanie Hsiao Yu Lee ◽  
Iftekhar Kalsekar ◽  
Paul Coplan ◽  
...  

Aim: To compare outcomes among patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing outpatient ventricular tachycardia (VT) catheter ablation using intracardiac echocardiography (ICE) versus no ICE. Patients & methods: Patients were classified into ICE (n = 1143)/non-ICE (n = 1677) groups based on ICE procedure codes. Patients in each group were propensity matched on study covariates. Survival analyses were used to assess outcomes. To examine residual confounding, falsification outcomes were evaluated. Results: ICE patients had a 24% lower risk of all-cause readmissions, 24% lower risk of cardiovascular-related and 20% lower risk of VT-related readmissions compared with non-ICE patients. Falsification analyses for ICE use association were nonsignificant. Conclusion: Patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing VT ablation with ICE use had significantly lower likelihood of VT-related readmission.


Sign in / Sign up

Export Citation Format

Share Document